ResearcherFirst Affiliated Hospital of Zhengzhou UniversityActive in the last 2 years

Penglei Ge

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9835-1591; OpenAlex author ID A5073927500. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2024: 1 paper

Papers 1

Identifying drug candidates for pancreatic ductal adenocarcinoma based on integrative multiomics analysis. Co-author DOI 10.21037/jgo-23-985 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Huahu Guo · 1 shared paper, 2024 · strength 0.21
- Paper Identifying drug candidates for pancreatic ductal adenocarcinoma based on integrative multiomics analysis. DOI 10.21037/jgo-23-985 ↗
Zhiqiang Gao · 1 shared paper, 2024 · strength 0.21
- Paper Identifying drug candidates for pancreatic ductal adenocarcinoma based on integrative multiomics analysis. DOI 10.21037/jgo-23-985 ↗
Shishi Qiao · 1 shared paper, 2024 · strength 0.21
- Paper Identifying drug candidates for pancreatic ductal adenocarcinoma based on integrative multiomics analysis. DOI 10.21037/jgo-23-985 ↗
Huayu Yang · 1 shared paper, 2024 · strength 0.21
- Paper Identifying drug candidates for pancreatic ductal adenocarcinoma based on integrative multiomics analysis. DOI 10.21037/jgo-23-985 ↗
Yang Wu · 1 shared paper, 2024 · strength 0.21
- Paper Identifying drug candidates for pancreatic ductal adenocarcinoma based on integrative multiomics analysis. DOI 10.21037/jgo-23-985 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.